Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eileen M Handberg

Showing results (91-100 of 108) with videos related to

Pageof 11
Sort By:
Journal of Interventional Cardiology|October 30, 2010
An intravascular ultrasound analysis in women experiencing chest pain in the absence of obstructive coronary artery disease: a substudy from the National Heart, Lung and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE)Matheen A Khuddus, Carl J Pepine, Eileen M Handberg, et al.
Journal of Women'S Health (2002)|October 13, 2011
Relationships between cardiovascular disease risk factors and depressive symptoms as predictors of cardiovascular disease events in womenThomas Rutledge, Sarah E Linke, B Delia Johnson, et al.
Clinical Cardiology|December 23, 2016
Myocardial tissue deformation is reduced in subjects with coronary microvascular dysfunction but not rescued by treatment with ranolazineMichael D Nelson, Behzad Sharif, Jaime L Shaw, et al.
Journal of the American College of Cardiology|May 16, 2015
2015 ACC Health Policy Statement on Cardiovascular Team-Based Care and the Role of Advanced Practice ProvidersJohn E Brush, Eileen M Handberg, Cathleen Biga, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 8, 2020
Coronary Vascular Function and Cardiomyocyte Injury: A Report From the WISE-CVDAhmed AlBadri, Janet Wei, Odayme Quesada, et al.
JMIR Research Protocols|December 22, 2017
Daily Activity Measured With Wearable Technology as a Novel Measurement of Treatment Effect in Patients With Coronary Microvascular Dysfunction: Substudy of a Randomized Controlled Crossover TrialKade Birkeland, Raj M Khandwalla, Ilan Kedan, et al.
Journal of Interventional Cardiology|November 28, 2019
Prevalence of Coronary Endothelial and Microvascular Dysfunction in Women with Symptoms of Ischemia and No Obstructive Coronary Artery Disease Is Confirmed by a New Cohort: The NHLBI-Sponsored Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction (WISE-CVD)R David Anderson, John W Petersen, Puja K Mehta, et al.
Frontiers in Cardiovascular Medicine|June 16, 2023
Autoimmune rheumatic diseases in women with coronary microvascular dysfunction: a report from the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction (WISE-CVD) projectMelanie T Chen, Joseph Chang, Ashley S Manchanda, et al.
JAMA|December 6, 2003
A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trialCarl J Pepine, Eileen M Handberg, Rhonda M Cooper-DeHoff, et al.
International Journal of Cardiology|February 11, 2020
Resting coronary velocity and myocardial performance in women with impaired coronary flow reserve: Results from the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction (WISE-CVD) studyNissi Suppogu, Janet Wei, Michael D Nelson, et al.
Pageof 11

Showing results (91-100 of 108) with videos related to

Sort By:
Pageof 11
Journal of Interventional Cardiology|October 30, 2010
An intravascular ultrasound analysis in women experiencing chest pain in the absence of obstructive coronary artery disease: a substudy from the National Heart, Lung and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE)Matheen A Khuddus, Carl J Pepine, Eileen M Handberg, et al.
Journal of Women'S Health (2002)|October 13, 2011
Relationships between cardiovascular disease risk factors and depressive symptoms as predictors of cardiovascular disease events in womenThomas Rutledge, Sarah E Linke, B Delia Johnson, et al.
Clinical Cardiology|December 23, 2016
Myocardial tissue deformation is reduced in subjects with coronary microvascular dysfunction but not rescued by treatment with ranolazineMichael D Nelson, Behzad Sharif, Jaime L Shaw, et al.
Journal of the American College of Cardiology|May 16, 2015
2015 ACC Health Policy Statement on Cardiovascular Team-Based Care and the Role of Advanced Practice ProvidersJohn E Brush, Eileen M Handberg, Cathleen Biga, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 8, 2020
Coronary Vascular Function and Cardiomyocyte Injury: A Report From the WISE-CVDAhmed AlBadri, Janet Wei, Odayme Quesada, et al.
JMIR Research Protocols|December 22, 2017
Daily Activity Measured With Wearable Technology as a Novel Measurement of Treatment Effect in Patients With Coronary Microvascular Dysfunction: Substudy of a Randomized Controlled Crossover TrialKade Birkeland, Raj M Khandwalla, Ilan Kedan, et al.
Journal of Interventional Cardiology|November 28, 2019
Prevalence of Coronary Endothelial and Microvascular Dysfunction in Women with Symptoms of Ischemia and No Obstructive Coronary Artery Disease Is Confirmed by a New Cohort: The NHLBI-Sponsored Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction (WISE-CVD)R David Anderson, John W Petersen, Puja K Mehta, et al.
Frontiers in Cardiovascular Medicine|June 16, 2023
Autoimmune rheumatic diseases in women with coronary microvascular dysfunction: a report from the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction (WISE-CVD) projectMelanie T Chen, Joseph Chang, Ashley S Manchanda, et al.
JAMA|December 6, 2003
A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trialCarl J Pepine, Eileen M Handberg, Rhonda M Cooper-DeHoff, et al.
International Journal of Cardiology|February 11, 2020
Resting coronary velocity and myocardial performance in women with impaired coronary flow reserve: Results from the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction (WISE-CVD) studyNissi Suppogu, Janet Wei, Michael D Nelson, et al.
Pageof 11